Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock OTC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market sale Chief Executive Officer sold 15,000 shares at an average $19.32 ($289,841)
  8. 4 Open-market sale President & CSO sold 15,000 shares at an average $19.32 ($289,841)
  9. 4 Open-market sale Chief Dev Operations Officer sold 1,974 shares at $20.00 ($39,480)
  10. 4 Open-market sale EVP, CBO, GC & Secretary sold 9,660 shares at an average $19.73 ($190,627)
  11. 4 Open-market sale President & CSO sold 15,000 shares at an average $19.63 ($294,414)
  12. 4 Open-market sale Chief Executive Officer sold 15,000 shares at an average $19.63 ($294,414)
  13. 4 Open-market sale Chief Executive Officer sold 20,000 shares at an average $19.63 ($392,519)
  14. 4 Open-market sale President & CSO sold 20,000 shares at an average $19.63 ($392,519)
  15. 4 Exercise or conversion Director acquired 3,030 shares (option exercise)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale President & CSO sold 20,000 shares at an average $22.37 ($447,381)
  19. 4 Open-market sale Chief Executive Officer sold 20,000 shares at an average $22.37 ($447,381)
  20. 4 Derivatives Options or other derivatives

Page 15 of 31 · 601 filings